shortagewatch

Home / Companies / Odan

Company family

Odan: medicine shortages

As of 2 Nov 2026, 41 Odan products have a reported shortage across 1 countries, covering 31 medicines.

Products short41rank #44 of 464
Medicines31active ingredients
Countries1/16
New in 90 days00 vs market pace
Typical duration10.5 yearsmedian so far
Manufacturing98%demand-driven 2%

Where

Canada41

Which therapeutic classes

Sensory organs28Various4Nervous system2Dermatologicals2Respiratory system1Digestive tract and metabolism1Cardiovascular system1Blood1Genito-urinary system and sex hormones1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
OdanOdan: Manufacturing problem 39 (95%)95%Odan: Increased demand 1 (2%)Odan: Not stated 1 (2%)All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

00001Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0NovDec: 0Jan ’26: 1Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0257102017: 420172018: 1020182019: 820192020: 520202021: 320212022: 720222023: 1020232024: 420242025: 220252026: 12026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Odan41

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Odan: 41 / 31Odan

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Pilocarpine315 Apr 2016Manufacturing problem2/16
Acetylsalicylic Acid215 Apr 2016Manufacturing problem7/16
Chloramphenicol215 Apr 2016Manufacturing problem3/16
Erythromycin229 Sep 2017Increased demand2/16
Gentamicin215 Apr 2016Manufacturing problem2/16
Timolol215 Apr 2016Manufacturing problem7/16
Artificial Tears and Other Indifferent Preparations115 Apr 2016Manufacturing problem5/16
Atropine115 Apr 2016Manufacturing problem1/16
Combinations115 Apr 2016Manufacturing problem1/16
Combinations115 Apr 2016Manufacturing problem1/16
Combinations Of Different Antibiotics115 Apr 2016Manufacturing problem3/16
Cyclopentolate115 Apr 2016Manufacturing problem3/16
Dexamethasone115 Apr 2016Manufacturing problem2/16
Dexamethasone and Antiinfectives115 Apr 2016Manufacturing problem5/16
Docusate Sodium115 Apr 2016Manufacturing problem1/16
Fluorescein115 Apr 2016Manufacturing problem5/16
Fluorescein, Combinations115 Apr 2016Manufacturing problem1/16
Hydrocortisone123 Jan 2026Manufacturing problem1/16
Hydrocortisone and Antiinfectives115 Apr 2016Manufacturing problem1/16
Lidocaine121 Jun 2016Manufacturing problem1/16
Naphazoline115 Apr 2016Manufacturing problem2/16
Phenylephrine115 Apr 2016Manufacturing problem2/16
Phenylephrine, Combinations115 Apr 2016Manufacturing problem1/16
Polystyrene Sulfonate11 Nov 2024Manufacturing problem3/16
Prednisolone and Antiinfectives115 Apr 2016Manufacturing problem1/16
Protirelin115 Apr 2016Manufacturing problem1/16
Proxymetacaine115 Apr 2016Manufacturing problem2/16
Rose Bengal Sodium115 Apr 2016Manufacturing problem1/16
Sulfacetamide115 Apr 2016Manufacturing problem1/16
Tropicamide115 Apr 2016Manufacturing problem5/16
Yohimbine1not givenNot stated1/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.